Stocks That Hit 52-Week Lows On Thursday
Thursday morning, 158 companies reached new 52-week lows.
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 13)
48 Biggest Movers From Yesterday
Gainers
Welbilt, Inc. (NYSE: WBT) shares surged 44.5% to close at $22.58 on Wednesday after The Middleby Corporation announced plans to acquire the company.
SVB Leerink Initiates Coverage On Design Therapeutics with Outperform Rating, Announces Price Target of $36
SVB Leerink analyst Joseph Schwartz initiates coverage on Design Therapeutics (NASDAQ:DSGN) with a Outperform rating and announces Price Target of $36.
Goldman Sachs Initiates Coverage On Design Therapeutics with Neutral Rating, Announces Price Target of $28
Goldman Sachs analyst Graig Suvannavejh initiates coverage on Design Therapeutics (NASDAQ:DSGN) with a Neutral rating and announces Price Target of $28.